ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,281,389 | -22.9% | 344,499 | -0.2% | 0.04% | -18.9% |
| Q2 2023 | $15,924,999 | +23.7% | 345,220 | +7.5% | 0.05% | +20.5% |
| Q1 2023 | $12,872,942 | -13.6% | 321,021 | -0.1% | 0.04% | -18.5% |
| Q4 2022 | $14,891,991 | -44.2% | 321,433 | -50.1% | 0.05% | +1.9% |
| Q3 2022 | $26,701,543 | -0.8% | 644,798 | +42.9% | 0.05% | +6.0% |
| Q2 2022 | $26,923,563 | -18.7% | 451,276 | -1.1% | 0.05% | +6.4% |
| Q1 2022 | $33,122,209 | +71.4% | 456,106 | +98.5% | 0.05% | -4.1% |
| Q4 2021 | $19,321,000 | -2.1% | 229,769 | +5.1% | 0.05% | -10.9% |
| Q3 2021 | $19,726,000 | -45.3% | 218,713 | -42.1% | 0.06% | +5.8% |
| Q2 2021 | $36,038,000 | +118.7% | 377,956 | +161.1% | 0.05% | +4.0% |
| Q1 2021 | $16,482,000 | -27.1% | 144,755 | -11.3% | 0.05% | -29.6% |
| Q4 2020 | $22,602,000 | +21.4% | 163,274 | -27.9% | 0.07% | +6.0% |
| Q3 2020 | $18,624,000 | -47.6% | 226,597 | -50.1% | 0.07% | -4.3% |
| Q2 2020 | $35,528,000 | +34.8% | 454,216 | -23.4% | 0.07% | +6.1% |
| Q1 2020 | $26,358,000 | -16.6% | 593,234 | -19.8% | 0.07% | +3.1% |
| Q4 2019 | $31,586,000 | +12.1% | 739,524 | +12.3% | 0.06% | +14.3% |
| Q3 2019 | $28,180,000 | -25.3% | 658,710 | +10.9% | 0.06% | -24.3% |
| Q2 2019 | $37,718,000 | +85.3% | 593,982 | +102.5% | 0.07% | -7.5% |
| Q1 2019 | $20,350,000 | +165.9% | 293,390 | +66.7% | 0.08% | +142.4% |
| Q4 2018 | $7,654,000 | +5.8% | 176,025 | +85.7% | 0.03% | +22.2% |
| Q3 2018 | $7,236,000 | -52.3% | 94,783 | -52.0% | 0.03% | -53.4% |
| Q2 2018 | $15,182,000 | +12.7% | 197,503 | -25.2% | 0.06% | +7.4% |
| Q1 2018 | $13,467,000 | +9.2% | 264,115 | -0.7% | 0.05% | +12.5% |
| Q4 2017 | $12,338,000 | -12.7% | 266,020 | +0.2% | 0.05% | -21.3% |
| Q3 2017 | $14,136,000 | -3.8% | 265,408 | +12.2% | 0.06% | -9.0% |
| Q2 2017 | $14,699,000 | +30.9% | 236,653 | +42.8% | 0.07% | +31.4% |
| Q1 2017 | $11,230,000 | -32.5% | 165,685 | -29.9% | 0.05% | -34.6% |
| Q4 2016 | $16,626,000 | +0.3% | 236,467 | +1.2% | 0.08% | +6.8% |
| Q3 2016 | $16,569,000 | +49.1% | 233,569 | +2.8% | 0.07% | +46.0% |
| Q2 2016 | $11,113,000 | -28.9% | 227,213 | -8.0% | 0.05% | -28.6% |
| Q1 2016 | $15,638,000 | -44.2% | 246,999 | -1.2% | 0.07% | -43.1% |
| Q4 2015 | $28,039,000 | +121.9% | 249,948 | +90.5% | 0.12% | +136.5% |
| Q3 2015 | $12,636,000 | +6.7% | 131,198 | +13.4% | 0.05% | +10.6% |
| Q2 2015 | $11,842,000 | +65.9% | 115,652 | +0.6% | 0.05% | +62.1% |
| Q1 2015 | $7,139,000 | +161.5% | 114,976 | +84.8% | 0.03% | +163.6% |
| Q4 2014 | $2,730,000 | -22.2% | 62,210 | +0.3% | 0.01% | -26.7% |
| Q3 2014 | $3,510,000 | +275.0% | 62,011 | +197.4% | 0.02% | +275.0% |
| Q2 2014 | $936,000 | -8.1% | 20,852 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,019,000 | – | 20,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |